Literature DB >> 2408957

Abnormal natural killer cytotoxicity in primary biliary cirrhosis: evidence for a functional deficiency of cytolytic effector cells.

S P James, E A Jones.   

Abstract

The in vitro cytotoxic activity of peripheral blood lymphocytes from patients with primary biliary cirrhosis was investigated to determine the mechanism of deficient spontaneous cell-mediated cytotoxicity in this disease. Using 51Cr-labeled Chang or K562 target cells, it was found that patients' lymphocytes mediated less natural killer cytotoxicity than lymphocytes from normal controls. Antibody-dependent cytotoxicity was normal in primary biliary cirrhosis. The natural killer activity of normal lymphocytes was inhibited neither by serum nor by lymphocytes from patients with primary biliary cirrhosis. The percentage of lymphocytes from patients that bound to target cells was normal. Furthermore, the percentages of lymphocytes that reacted with the monoclonal antibodies anti-Leu-7 and anti-Leu-11 were normal in patients. The percentage of lymphocytes that reacted with both anti-Leu-2 and anti-Leu-7, a subpopulation of cells that has low natural killer activity, was also normal in primary biliary cirrhosis. Interferon and interleukin-2 both augmented cytotoxic function of lymphocytes from primary biliary cirrhosis patients, however, the levels of cytotoxicity induced by these agents were less than corresponding levels exhibited by normal lymphocytes when similarly stimulated. These findings indicate that patients with primary biliary cirrhosis have diminished natural killer activity due to a functional defect of cytolytic effector cells.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2408957     DOI: 10.1016/0016-5085(85)90758-9

Source DB:  PubMed          Journal:  Gastroenterology        ISSN: 0016-5085            Impact factor:   22.682


  6 in total

Review 1.  Natural killer cells and autoimmunity.

Authors:  E Grunebaum; E Malatzky-Goshen; Y Shoenfeld
Journal:  Immunol Res       Date:  1989       Impact factor: 2.829

2.  Fibrosis and subsequent cytopenias are associated with basic fibroblast growth factor-deficient pluripotent mesenchymal stromal cells in large granular lymphocyte leukemia.

Authors:  Adam W Mailloux; Ling Zhang; Lynn Moscinski; John M Bennett; Lili Yang; Sean J Yoder; Gregory Bloom; Cody Wei; Sheng Wei; Lubomir Sokol; Thomas P Loughran; Pearlie K Epling-Burnette
Journal:  J Immunol       Date:  2013-09-06       Impact factor: 5.422

3.  Natural killer cell activity in patients with liver cirrhosis relative to severity of liver damage.

Authors:  W L Chuang; H W Liu; W Y Chang; S C Chen; M Y Hsieh; L Y Wang
Journal:  Dig Dis Sci       Date:  1991-03       Impact factor: 3.199

4.  Natural killer and activated killer activities in chronic liver disease and hepatocellular carcinoma: evidence for a decreased lymphokine-induced activity of effector cells.

Authors:  H Hirofuji; S Kakumu; A Fuji; Y Ohtani; K Murase; H Tahara
Journal:  Clin Exp Immunol       Date:  1987-05       Impact factor: 4.330

5.  Clonal analysis of liver-derived T cells of patients with primary biliary cirrhosis.

Authors:  R M Hoffmann; G R Pape; U Spengler; E P Rieber; J Eisenburg; J Döhrmann; G Paumgartner; G Riethmüller
Journal:  Clin Exp Immunol       Date:  1989-05       Impact factor: 4.330

6.  Ursodeoxycholic acid corrects defective natural killer activity by inhibiting prostaglandin E2 production in primary biliary cirrhosis.

Authors:  Y Nishigaki; H Ohnishi; H Moriwaki; Y Muto
Journal:  Dig Dis Sci       Date:  1996-07       Impact factor: 3.199

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.